Cargando...
Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone
One objective in developing adverse outcome pathways (AOPs) is to connect biological changes that are relevant to risk assessors (i.e., fecundity) to molecular and cellular-level alterations that might be detectable at earlier stages of a chemical exposure. Here, we examined biochemical responses of...
Gardado en:
| Publicado en: | Aquat Toxicol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6145081/ https://ncbi.nlm.nih.gov/pubmed/28129603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.aquatox.2017.01.001 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|